Syndax Pharmaceuticals (SNDX) FCF Margin (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) FCF Margin (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,357.00 |
| Dec 31, 2025 | 5,258.00 |
| Sep 30, 2025 | 7,753.00 |
| Jun 30, 2025 | 24,352.00 |
| Mar 31, 2025 | 27,243.00 |
| Dec 31, 2024 | -24,866.00 |
| Sep 30, 2024 | 154,842.00 |
| Dec 31, 2021 | 28,113.00 |
| Sep 30, 2021 | 614,276.00 |
| Jun 30, 2021 | -38,417.00 |
| Mar 31, 2021 | -184,674.00 |
| Dec 31, 2020 | 71,428.00 |
| Sep 30, 2020 | 82,058.00 |
| Jun 30, 2020 | -144,644.00 |
| Mar 31, 2020 | -85,264.00 |
| Dec 31, 2019 | -109,881.00 |
| Sep 30, 2019 | 105,435.00 |
| Jun 30, 2019 | 113,615.00 |
| Mar 31, 2019 | -47,853.00 |
| Dec 31, 2018 | 91,072.00 |